Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Global Cord Blood Corporation Files Annual Report on Form 20-F 2021-07-30 04:16
Bon Natural Life Limited Breaks Ground on Its Third Production Facility in Yumen 2021-07-29 21:00
I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company up to US$40 Million 2021-07-29 20:00
MGI Australia Demo Lab Opens to Support APAC Customers 2021-07-29 19:18
Exyte Empowers the Biopharmaceutical Industry: First ExyCell(R) Facility Launched in Shanghai 2021-07-29 16:25
GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit 2021-07-28 19:30
BIOTRONIK Applauded by Frost & Sullivan for Its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm 2021-07-28 18:00
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China 2021-07-28 13:47
Deep Longevity Repurposes a Blood Aging Clock for Saliva Samples 2021-07-27 21:39
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions 2021-07-27 14:05
TCI Japan Successfully Isolated TCI 378 from Kimchi - the Patented Ingredients for Health Foods 2021-07-27 12:32
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference 2021-07-26 20:00
Deep Longevity Releases an AI-based Predictor of COVID Time-To-Death 2021-07-26 19:08
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors 2021-07-26 17:00
Laekna Therapeutics will present two clinical study results in ESMO 2021 2021-07-26 13:26
Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections 2021-07-26 08:44
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors 2021-07-26 08:00
FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH 2021-07-22 21:50
Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB-3115 (Proposed Biosimilar to Ustekinumab) 2021-07-22 13:00
Menarini Asia-Pacific strengthens Men's Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly 2021-07-22 10:00
1 231 232 233 234 235 451